US Stock MarketDetailed Quotes

Mineralys Therapeutics (MLYS)

Watchlist
  • 29.260
  • -0.470-1.58%
Close May 12 16:00 ET
  • 29.260
  • 0.0000.00%
Post 17:42 ET
2.41BMarket Cap-14.85P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mineralys Therapeutics (MLYS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.23%-39.47M
14.37%-142.42M
43.32%-37.89M
42.47%-28.87M
-0.08%-30.17M
-137.67%-45.49M
-104.89%-166.31M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
Net income from continuing operations
6.80%-39.34M
13.02%-154.65M
34.14%-32.23M
34.45%-36.93M
-5.51%-43.27M
-33.97%-42.21M
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
Depreciation and amortization
-60.00%6K
37.21%59K
-13.33%13K
36.36%15K
77.78%16K
87.50%15K
--43K
--15K
--11K
--9K
Other non cash items
-342.16%-4.63M
-5.04%-9.88M
-214.73%-4.21M
11.65%-2.4M
21.71%-2.23M
58.31%-1.05M
-37.00%-9.41M
35.29%-1.34M
-38.23%-2.71M
-43.64%-2.85M
Change In working capital
65.01%-2.06M
-71.32%2.73M
65.78%-6.74M
-19.55%4.6M
-0.64%10.77M
-146.45%-5.89M
227.47%9.52M
-394.83%-19.71M
39.02%5.72M
243.71%10.83M
-Change in receivables
455.77%289K
-139.15%-166K
-284.69%-181K
-56.52%10K
-125.54%-47K
-56.30%52K
219.44%424K
-67.33%98K
110.50%23K
210.84%184K
-Change in prepaid assets
55.69%-1.95M
-49.95%2.47M
150.05%1.57M
30.36%3.56M
47.54%1.74M
-205.70%-4.4M
151.78%4.94M
-156.38%-3.13M
190.91%2.73M
132.71%1.18M
-Change in payables and accrued expense
74.00%-402K
-89.74%427K
51.24%-8.13M
-65.25%1.03M
-4.20%9.07M
-118.40%-1.55M
72.38%4.16M
-444.72%-16.67M
-59.60%2.96M
351.11%9.47M
Cash from discontinued investing activities
Operating cash flow
13.23%-39.47M
14.37%-142.42M
43.32%-37.89M
42.47%-28.87M
-0.08%-30.17M
-137.67%-45.49M
-104.89%-166.31M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
Investing cash flow
Cash flow from continuing investing activities
51.61%-44.94M
-439.04%-389.75M
-223.84%-103.49M
-289.07%-150.51M
-654.30%-42.88M
-65.99%-92.88M
171.64%114.96M
1,133.13%83.57M
1,886.65%79.61M
147.93%7.74M
Net PPE purchase and sale
----
84.38%-15K
---15K
--0
--0
--0
---96K
--0
---37K
--0
Net investment purchase and sale
51.61%-44.94M
-438.74%-389.74M
-223.82%-103.47M
-288.98%-150.51M
-654.30%-42.88M
-66.17%-92.88M
171.70%115.06M
1,133.13%83.57M
1,887.57%79.64M
147.93%7.74M
Cash from discontinued investing activities
Investing cash flow
51.61%-44.94M
-439.04%-389.75M
-223.84%-103.49M
-289.07%-150.51M
-654.30%-42.88M
-65.99%-92.88M
171.64%114.96M
1,133.13%83.57M
1,886.65%79.61M
147.93%7.74M
Financing cash flow
Cash flow from continuing financing activities
-87.18%24.27M
408.86%591M
107,345.56%96.7M
29,518,900.00%295.19M
6,567.76%9.83M
62.88%189.28M
-42.86%116.14M
21.62%90K
-100.54%-1K
73.84%-152K
Net common stock issuance
-89.31%20.22M
398.33%578.36M
--91.95M
--288.59M
14,528.33%8.66M
62.91%189.17M
-42.83%116.06M
--0
--0
89.67%-60K
Proceeds from stock option exercised by employees
3,196.75%4.06M
2,415.25%13.03M
3,594.16%5.06M
16,460.00%6.62M
535.94%1.22M
-17.45%123K
100.78%518K
85.14%137K
-78.26%40K
--192K
Net other financing activities
90.00%-1K
10.11%-391K
-548.94%-305K
29.27%-29K
83.45%-47K
84.13%-10K
---435K
---47K
---41K
---284K
Cash from discontinued financing activities
Financing cash flow
-87.18%24.27M
408.86%591M
107,345.56%96.7M
29,518,900.00%295.19M
6,567.76%9.83M
62.88%189.28M
-42.86%116.14M
21.62%90K
-100.54%-1K
73.84%-152K
Net cash flow
Beginning cash position
51.56%172.92M
131.40%114.09M
123.69%217.6M
50.01%101.79M
82.49%165.01M
131.40%114.09M
-43.78%49.3M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
Current changes in cash
-218.12%-60.14M
-9.19%58.83M
-365.66%-44.68M
293.67%115.81M
-180.20%-63.22M
23.84%50.92M
268.73%64.79M
145.46%16.82M
298.23%29.42M
39.20%-22.56M
End cash Position
-31.65%112.78M
51.56%172.92M
51.56%172.92M
123.69%217.6M
50.01%101.79M
82.49%165.01M
131.40%114.09M
131.40%114.09M
12.72%97.27M
-32.91%67.86M
Free cash flow
13.23%-39.47M
14.41%-142.43M
43.30%-37.9M
42.51%-28.87M
-0.08%-30.17M
-136.94%-45.49M
-105.01%-166.41M
-130.64%-66.84M
-163.90%-50.22M
-47.88%-30.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.23%-39.47M14.37%-142.42M43.32%-37.89M42.47%-28.87M-0.08%-30.17M-137.67%-45.49M-104.89%-166.31M-130.64%-66.84M-163.71%-50.19M-47.88%-30.15M
Net income from continuing operations 6.80%-39.34M13.02%-154.65M34.14%-32.23M34.45%-36.93M-5.51%-43.27M-33.97%-42.21M-147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M
Depreciation and amortization -60.00%6K37.21%59K-13.33%13K36.36%15K77.78%16K87.50%15K--43K--15K--11K--9K
Other non cash items -342.16%-4.63M-5.04%-9.88M-214.73%-4.21M11.65%-2.4M21.71%-2.23M58.31%-1.05M-37.00%-9.41M35.29%-1.34M-38.23%-2.71M-43.64%-2.85M
Change In working capital 65.01%-2.06M-71.32%2.73M65.78%-6.74M-19.55%4.6M-0.64%10.77M-146.45%-5.89M227.47%9.52M-394.83%-19.71M39.02%5.72M243.71%10.83M
-Change in receivables 455.77%289K-139.15%-166K-284.69%-181K-56.52%10K-125.54%-47K-56.30%52K219.44%424K-67.33%98K110.50%23K210.84%184K
-Change in prepaid assets 55.69%-1.95M-49.95%2.47M150.05%1.57M30.36%3.56M47.54%1.74M-205.70%-4.4M151.78%4.94M-156.38%-3.13M190.91%2.73M132.71%1.18M
-Change in payables and accrued expense 74.00%-402K-89.74%427K51.24%-8.13M-65.25%1.03M-4.20%9.07M-118.40%-1.55M72.38%4.16M-444.72%-16.67M-59.60%2.96M351.11%9.47M
Cash from discontinued investing activities
Operating cash flow 13.23%-39.47M14.37%-142.42M43.32%-37.89M42.47%-28.87M-0.08%-30.17M-137.67%-45.49M-104.89%-166.31M-130.64%-66.84M-163.71%-50.19M-47.88%-30.15M
Investing cash flow
Cash flow from continuing investing activities 51.61%-44.94M-439.04%-389.75M-223.84%-103.49M-289.07%-150.51M-654.30%-42.88M-65.99%-92.88M171.64%114.96M1,133.13%83.57M1,886.65%79.61M147.93%7.74M
Net PPE purchase and sale ----84.38%-15K---15K--0--0--0---96K--0---37K--0
Net investment purchase and sale 51.61%-44.94M-438.74%-389.74M-223.82%-103.47M-288.98%-150.51M-654.30%-42.88M-66.17%-92.88M171.70%115.06M1,133.13%83.57M1,887.57%79.64M147.93%7.74M
Cash from discontinued investing activities
Investing cash flow 51.61%-44.94M-439.04%-389.75M-223.84%-103.49M-289.07%-150.51M-654.30%-42.88M-65.99%-92.88M171.64%114.96M1,133.13%83.57M1,886.65%79.61M147.93%7.74M
Financing cash flow
Cash flow from continuing financing activities -87.18%24.27M408.86%591M107,345.56%96.7M29,518,900.00%295.19M6,567.76%9.83M62.88%189.28M-42.86%116.14M21.62%90K-100.54%-1K73.84%-152K
Net common stock issuance -89.31%20.22M398.33%578.36M--91.95M--288.59M14,528.33%8.66M62.91%189.17M-42.83%116.06M--0--089.67%-60K
Proceeds from stock option exercised by employees 3,196.75%4.06M2,415.25%13.03M3,594.16%5.06M16,460.00%6.62M535.94%1.22M-17.45%123K100.78%518K85.14%137K-78.26%40K--192K
Net other financing activities 90.00%-1K10.11%-391K-548.94%-305K29.27%-29K83.45%-47K84.13%-10K---435K---47K---41K---284K
Cash from discontinued financing activities
Financing cash flow -87.18%24.27M408.86%591M107,345.56%96.7M29,518,900.00%295.19M6,567.76%9.83M62.88%189.28M-42.86%116.14M21.62%90K-100.54%-1K73.84%-152K
Net cash flow
Beginning cash position 51.56%172.92M131.40%114.09M123.69%217.6M50.01%101.79M82.49%165.01M131.40%114.09M-43.78%49.3M12.72%97.27M-32.91%67.86M-34.60%90.42M
Current changes in cash -218.12%-60.14M-9.19%58.83M-365.66%-44.68M293.67%115.81M-180.20%-63.22M23.84%50.92M268.73%64.79M145.46%16.82M298.23%29.42M39.20%-22.56M
End cash Position -31.65%112.78M51.56%172.92M51.56%172.92M123.69%217.6M50.01%101.79M82.49%165.01M131.40%114.09M131.40%114.09M12.72%97.27M-32.91%67.86M
Free cash flow 13.23%-39.47M14.41%-142.43M43.30%-37.9M42.51%-28.87M-0.08%-30.17M-136.94%-45.49M-105.01%-166.41M-130.64%-66.84M-163.90%-50.22M-47.88%-30.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -